Better understanding of the different mutations that drive GIST is leading to new paradigms of tailored treatment that break many norms of chemotherapy, especially in management of progression.
Related Articles
Senza categoria
Newsround
Senza categoria
When is it OK to randomise cancer patients to placebo?
Senza categoria